USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
New England Rare Reagents
Address:
3 Burnham Road
Gorham, ME 04038 1906
Phone:
(207) 233-9925
URL:
N/A
EIN:
320032289
DUNS:
602455896
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $329,607.00 3

Award List:

Antibodies Against Amyloid Beta-Protein Intermediates

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$106,615.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Recent data from several labs suggest that intermediates formed during fibril formation, referred to as protofibrils (PFs), may contribute to neuronal injury in Alzheimer's disease (AD). Currently, there are no antibodies in the marketplace that can distinguish… More

Novel Reagent Development for Chronic Wasting Disease

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$79,912.00
Agency:
USDA
Principal Investigator:
Abstract:
Chronic wasting disease (CWD) in elk and deer, and scrapie in sheep are a family of degenerative, central nervous system diseases known as transmissible spongiform encephalopathies (TSEs) or prion diseases. They are often called spongiform because of the post mortem appearance of hole-like… More

FY10-PHI01SBIR Phase I: Development of Soluble Analyte Amplification for PBP2a Detection

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$143,080.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is to develop a prototype feasibility assay for low level detection of methacillin resistant Staphlococcus aureus (MRSA) protein biomarker, Penicillin Binding Protein 2a (PBP2a), using an innovative, patented detection technology. The… More